Inhibikase Therapeutics, Inc. (IKT) SEC Filings https://www.inhibikase.com/investors/sec-filings/all-sec-filings/rss Inhibikase Therapeutics, Inc. (IKT) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_36dbb71928886c79e446b0ffcae1c0b0/inhibikase/files/theme/images/logo-sm.png Inhibikase Therapeutics, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001346824-26-000206/0001346824-26-000206.pdf Fri, 31 Jul 26 16:34:00 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001346824-26-000206/0001346824-26-000206.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001231919-26-000815/0001231919-26-000815.pdf Fri, 31 Jul 26 16:32:56 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001231919-26-000815/0001231919-26-000815.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-328467/0001193125-26-328467.pdf Fri, 31 Jul 26 16:06:30 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-328467/0001193125-26-328467.pdf <![CDATA[8-K - Current report]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-323651/0001193125-26-323651.pdf Wed, 29 Jul 26 16:06:17 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-323651/0001193125-26-323651.pdf <![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0002012383-26-002526/0002012383-26-002526.pdf Tue, 28 Jul 26 16:46:36 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0002012383-26-002526/0002012383-26-002526.pdf <![CDATA[8-K - Current report]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-313400/0001193125-26-313400.pdf Thu, 23 Jul 26 08:33:09 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-313400/0001193125-26-313400.pdf <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001231919-26-000769/0001231919-26-000769.pdf Fri, 17 Jul 26 17:55:07 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001231919-26-000769/0001231919-26-000769.pdf <![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001346824-26-000193/0001346824-26-000193.pdf Fri, 17 Jul 26 17:53:08 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001346824-26-000193/0001346824-26-000193.pdf <![CDATA[8-K - Current report]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-302580/0001193125-26-302580.pdf Tue, 14 Jul 26 08:11:39 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-302580/0001193125-26-302580.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290477/0001193125-26-290477.pdf Tue, 30 Jun 26 16:06:07 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290477/0001193125-26-290477.pdf